An open-label, phase I/II, multicenter dose escalation study of zosuquidar, daunorubicin, and cytarabine in patients ages 55-75 with newly diagnosed acute myeloid leukemia
Phase of Trial: Phase I/II
Latest Information Update: 12 Mar 2008
At a glance
- Drugs Cytarabine; Daunorubicin; Zosuquidar
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 12 Mar 2008 Status changed form recruiting to completed. Updated from ClinicalTrials.gov.
- 14 Dec 2005 New trial record.